Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

Cetin, Bulent; Afsar, Baris; Deger, Serpil; IŞIK GÖNÜL, İPEK; Gumusay, Ozge; ÖZET, AHMET; Benekli, Mustafa; Coskun, UĞUR; Buyukberber, Suleyman

doi:10.1007/s11255-013-0613-x

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

Copy For Citation

Cetin B., Afsar B., Deger S. M., IŞIK GÖNÜL İ., Gumusay O., ÖZET A., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.46, no.6, pp.1081-1087, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 46 Issue: 6
Publication Date: 2014
Doi Number: 10.1007/s11255-013-0613-x
Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1081-1087
Gazi University Affiliated: Yes

Abstract

There are no robust data on hemoglobin (Hb), lactate dehydrogenase (LDH), and calcium variability for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy. We aim to evaluate prognostic implications of Hb, LDH, and calcium variability and establish a novel risk stratification model in RCC patients receiving targeted therapies.